Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Acute bacterial exacerbation of chronic bronchitis
Age: Adult
Dose: Oral – 320 mg
Frequency: once daily
Duration: 5 days
Indication: Community-acquired pneumonia
Age: Adult
Condition: Mild to moderate
Dose: Oral – 320 mg
Frequency: once daily
Duration: 7 days

Child Dose

Clinical InformationAdministration Information
Age: Child
Dose: Safety and efficacy not established
Note: Safety and efficacy not established

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment: Creatinine Clearance (ml/min) less than 40 (or patient on haemodialysis/CAPD)
Dose: Tablet – 160 mg
Frequency: once daily
Note: CAPD refers to continuous ambulatory peritoneal dialysis
Administration
  • Can take with/without food
  • Take with water
Side Effect

Drug Interaction

Drug NameRisk Factors
Class IA (e.g. quinidine) or class III (e.g. amiodarone) Antiarrhythmics (Amiodarone, Flecainide, Propafenone, Quinidine, Disopyramide, Procainamide), Other drugs that prolong QT interval (e.g. erythromycin, TCAs, antipsychotic agents)
Additive effect on QT interval prolongation
Probenecid
Renal clearance reduced

Disease Interaction

Disease NameRisk Factors
No specific contraindications listed
Monitor for general drug reactions

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.